JPY 8530.0
(-0.92%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2018.56 Billion JPY | 16.14% |
2022 | 1737.99 Billion JPY | 16.0% |
2021 | 1498.27 Billion JPY | 5.3% |
2020 | 1422.82 Billion JPY | 1.9% |
2019 | 1396.24 Billion JPY | 8.07% |
2018 | 1291.98 Billion JPY | 4.2% |
2017 | 1239.95 Billion JPY | 3.71% |
2016 | 1195.54 Billion JPY | -17.28% |
2015 | 1445.22 Billion JPY | -9.64% |
2014 | 1599.42 Billion JPY | 10.1% |
2013 | 1452.75 Billion JPY | 19.27% |
2012 | 1218.05 Billion JPY | 5.5% |
2011 | 1154.57 Billion JPY | 5.9% |
2010 | 1090.21 Billion JPY | 0.55% |
2009 | 1084.29 Billion JPY | 13.43% |
2008 | 955.94 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 621.14 Billion JPY | 5.38% |
2024 Q2 | 589.41 Billion JPY | 13.45% |
2024 Q1 | 519.51 Billion JPY | -3.7% |
2023 Q2 | 499.19 Billion JPY | 11.34% |
2023 FY | 2018.56 Billion JPY | 16.14% |
2023 Q1 | 448.34 Billion JPY | -4.99% |
2023 Q4 | 539.48 Billion JPY | 1.49% |
2023 Q3 | 531.54 Billion JPY | 6.48% |
2022 FY | 1737.99 Billion JPY | 16.0% |
2022 Q1 | 380.3 Billion JPY | -2.7% |
2022 Q2 | 433.99 Billion JPY | 14.12% |
2022 Q4 | 471.87 Billion JPY | 4.44% |
2022 Q3 | 451.81 Billion JPY | 4.1% |
2021 FY | 1498.27 Billion JPY | 5.3% |
2021 Q1 | 336.78 Billion JPY | -5.36% |
2021 Q2 | 382.02 Billion JPY | 13.43% |
2021 Q3 | 388.6 Billion JPY | 1.72% |
2021 Q4 | 390.85 Billion JPY | 0.58% |
2020 Q1 | 339.56 Billion JPY | -7.6% |
2020 Q4 | 355.86 Billion JPY | -4.21% |
2020 Q3 | 371.51 Billion JPY | 4.39% |
2020 Q2 | 355.88 Billion JPY | 4.81% |
2020 FY | 1422.82 Billion JPY | 1.9% |
2019 Q3 | 357.62 Billion JPY | 0.13% |
2019 Q1 | 313.95 Billion JPY | -8.71% |
2019 FY | 1396.24 Billion JPY | 8.07% |
2019 Q4 | 367.48 Billion JPY | 2.76% |
2019 Q2 | 357.17 Billion JPY | 13.77% |
2018 Q4 | 343.9 Billion JPY | 4.29% |
2018 FY | 1291.98 Billion JPY | 4.2% |
2018 Q1 | 294.65 Billion JPY | -8.19% |
2018 Q2 | 323.67 Billion JPY | 9.85% |
2018 Q3 | 329.74 Billion JPY | 1.88% |
2017 Q3 | 323.66 Billion JPY | 2.69% |
2017 FY | 1239.95 Billion JPY | 3.71% |
2017 Q1 | 280.19 Billion JPY | -4.29% |
2017 Q2 | 315.16 Billion JPY | 12.48% |
2017 Q4 | 320.93 Billion JPY | -0.84% |
2016 FY | 1195.54 Billion JPY | -17.28% |
2016 Q4 | 292.75 Billion JPY | -3.2% |
2016 Q3 | 302.43 Billion JPY | -1.61% |
2016 Q2 | 307.38 Billion JPY | 8.78% |
2016 Q1 | 282.58 Billion JPY | -16.42% |
2015 FY | 1445.22 Billion JPY | -9.64% |
2015 Q1 | 385.07 Billion JPY | 0.0% |
2015 Q2 | 360.72 Billion JPY | -6.32% |
2015 Q3 | 361.34 Billion JPY | 0.17% |
2015 Q4 | 338.07 Billion JPY | -6.44% |
2014 Q2 | 386.34 Billion JPY | 2.99% |
2014 FY | 1599.42 Billion JPY | 10.1% |
2014 Q4 | - JPY | -100.0% |
2014 Q3 | 401.93 Billion JPY | 4.04% |
2014 Q1 | 375.12 Billion JPY | -0.82% |
2013 Q4 | 378.22 Billion JPY | 0.62% |
2013 FY | 1452.75 Billion JPY | 19.27% |
2013 Q1 | 325.49 Billion JPY | 10.88% |
2013 Q2 | 323.52 Billion JPY | -0.6% |
2013 Q3 | 375.88 Billion JPY | 16.18% |
2012 Q2 | 288 Billion JPY | 5.46% |
2012 Q3 | 311 Billion JPY | 7.99% |
2012 Q4 | 293.55 Billion JPY | -5.61% |
2012 FY | 1218.05 Billion JPY | 5.5% |
2012 Q1 | 273.1 Billion JPY | -6.21% |
2011 Q2 | 288.4 Billion JPY | 14.4% |
2011 FY | 1154.57 Billion JPY | 5.9% |
2011 Q4 | 291.18 Billion JPY | -3.54% |
2011 Q1 | 252.09 Billion JPY | -4.55% |
2011 Q3 | 301.88 Billion JPY | 4.68% |
2010 Q3 | 292.25 Billion JPY | 3.73% |
2010 Q1 | 266.82 Billion JPY | 1.23% |
2010 FY | 1090.21 Billion JPY | 0.55% |
2010 Q4 | 264.12 Billion JPY | -9.63% |
2010 Q2 | 281.73 Billion JPY | 5.59% |
2009 Q3 | 293.03 Billion JPY | 12.35% |
2009 Q2 | 260.83 Billion JPY | 0.0% |
2009 Q4 | 263.58 Billion JPY | -10.05% |
2009 FY | 1084.29 Billion JPY | 13.43% |
2008 FY | 955.94 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Kyowa Kirin Co., Ltd. | 442.23 Billion JPY | -356.449% |
Astellas Pharma Inc. | 1603.67 Billion JPY | -25.872% |
Chugai Pharmaceutical Co., Ltd. | 1111.36 Billion JPY | -81.629% |
Ono Pharmaceutical Co., Ltd. | 502.67 Billion JPY | -301.568% |
Santen Pharmaceutical Co., Ltd. | 301.96 Billion JPY | -568.477% |
JCR Pharmaceuticals Co., Ltd. | 42.87 Billion JPY | -4608.47% |
Daiichi Sankyo Company, Limited | 1601.68 Billion JPY | -26.028% |
Perseus Proteomics Inc. | 100.4 Million JPY | -2010385.847% |